Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics.

Hecking, Manfred; Sharif, Adnan; Eller, Kathrin; Jenssen, Trond

Hecking, Manfred; Sharif, Adnan; Eller, Kathrin; Jenssen, Trond.

Afiliación

Hecking M; Department of Internal Medicine III, Clinical Division of Nephrology & Dialysis, Medical University of Vienna, Vienna, Austria.
Sharif A; Department of Nephrology and Transplantation, Queen Elizabeth Hospital, Birmingham, UK.
Eller K; Clinical Division of Nephrology, Medical University of Graz, Graz, Austria.
Jenssen T; Department of Organ Transplantation, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

Transpl Int ; 34(1): 27-48, 2021 01.

Article en En | MEDLINE | ID: mdl-33135259

Asunto(s)

Diabetes Mellitus Tipo 2; Diabetes Mellitus; Trasplante de Riñón; Humanos; Hipoglucemiantes/uso terapéutico; Terapia de Inmunosupresión; Inmunosupresores/uso terapéutico; Complicaciones Posoperatorias; Estudios Retrospectivos; Factores de Riesgo

Palabras clave

atherosclerosis; cardiovascular diseases; chronic; diabetes mellitus; glucagon-like peptide-1 receptor; glucose; hypoglycemic agents; immunosuppression; insulin; prospective studies; renal insufficiency; retrospective studies; type 2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Riñón / Diabetes Mellitus / Diabetes Mellitus Tipo 2 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transpl Int Asunto de la revista: TRANSPLANTE Año: 2021 Tipo del documento: Article País de afiliación: Austria

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google